Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Codex DNA IncCommon Stock stock

Learn how to easily invest in Codex DNA IncCommon Stock stock.

Codex DNA, Inc. Common Stock
-$0.12 (-0.78%)

Codex DNA, Inc. Common Stock is a medical devices business based in the US. Codex DNA IncCommon Stock shares (DNAY) are listed on the NASDAQ and all prices are listed in US Dollars. Codex DNA IncCommon Stock employs 101 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Codex DNA IncCommon Stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DNAY – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Codex DNA IncCommon Stock stock price (NASDAQ: DNAY)

Use our graph to track the performance of DNAY stocks over time.

Codex DNA IncCommon Stock shares at a glance

Information last updated 2021-07-28.
52-week range$10.00 - $21.57
50-day moving average $17.74
200-day moving average $17.74
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Codex DNA IncCommon Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Codex DNA IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Codex DNA IncCommon Stock financials

Revenue TTM $7.5 million
Gross profit TTM $3.6 million
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin -287.01%
Book value N/A
Market capitalisation $452.8 million

TTM: trailing 12 months

Shorting Codex DNA IncCommon Stock shares

There are currently 464,438 Codex DNA IncCommon Stock shares held short by investors – that's known as Codex DNA IncCommon Stock's "short interest". This figure is 206.6% up from 151,469 last month.

There are a few different ways that this level of interest in shorting Codex DNA IncCommon Stock shares can be evaluated.

Codex DNA IncCommon Stock's "short interest ratio" (SIR)

Codex DNA IncCommon Stock's "short interest ratio" (SIR) is the quantity of Codex DNA IncCommon Stock shares currently shorted divided by the average quantity of Codex DNA IncCommon Stock shares traded daily (recently around 377591.8699187). Codex DNA IncCommon Stock's SIR currently stands at 1.23. In other words for every 100,000 Codex DNA IncCommon Stock shares traded daily on the market, roughly 1230 shares are currently held short.

To gain some more context, you can compare Codex DNA IncCommon Stock's short interest ratio against those of similar companies.

However Codex DNA IncCommon Stock's short interest can also be evaluated against the total number of Codex DNA IncCommon Stock shares, or, against the total number of tradable Codex DNA IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Codex DNA IncCommon Stock's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Codex DNA IncCommon Stock shares in existence, roughly 20 shares are currently held short) or 0.1003% of the tradable shares (for every 100,000 tradable Codex DNA IncCommon Stock shares, roughly 100 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Codex DNA IncCommon Stock.

Find out more about how you can short Codex DNA IncCommon Stock stock.

Codex DNA IncCommon Stock share dividends

We're not expecting Codex DNA IncCommon Stock to pay a dividend over the next 12 months.

You may also wish to consider:

Codex DNA IncCommon Stock overview

Codex DNA, Inc. , a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries. The company also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020.

Frequently asked questions

What percentage of Codex DNA IncCommon Stock is owned by insiders or institutions?
Currently 86.474% of Codex DNA IncCommon Stock shares are held by insiders and 0.215% by institutions.
How many people work for Codex DNA IncCommon Stock?
Latest data suggests 101 work at Codex DNA IncCommon Stock.
When does the fiscal year end for Codex DNA IncCommon Stock?
Codex DNA IncCommon Stock's fiscal year ends in December.
Where is Codex DNA IncCommon Stock based?
Codex DNA IncCommon Stock's address is: 9535 Waples Street, San Diego, CA, United States, 92121-2993

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site